Gene · 3785
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the design and development of chemical modulators of the voltage-gated potassium channels KV7.4 and KV7.5. | Expert Opin Drug Discov | 2025 | 39627683 | PubTator, text mining | PubMed |
| Whole exome sequencing revealed ultra-rare genetic variations in juvenile myoclonic epilepsy. | Neurol Sci | 2025 | 39616287 | PubTator, text mining | PubMed |
| Genetic neonatal seizures in the neonatal intensive care unit: Diagnostic and prognostic implications for three families. | Epileptic Disord | 2025 | 39570101 | PubTator, text mining | PubMed |
| Cerebellar Hypoplasia and Treatment Course of a Two-Month-Old Infant With KCNQ2 Epileptic Encephalopathy Due to a De Novo Variant and Review of the Literature. | Am J Med Genet A | 2025 | 39404469 | PubTator, text mining | PubMed |
| Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes. | Front Cell Neurosci | 2024 | 39926415 | PubTator, text mining | PubMed |
| Infantile epileptic spasms syndrome: an etiologic study of 361 patients with infantile epileptic spasms syndrome. | Front Pediatr | 2024 | 39850204 | PubTator, text mining | PubMed |
| Novel KCNQ2 Variants Related to a Variable Phenotypic Spectrum Ranging from Epilepsy with Auditory Features to Severe Developmental and Epileptic Encephalopathies. | Int J Mol Sci | 2024 | 39796146 | PubTator, text mining | PubMed |
| National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy. | J Med Genet | 2024 | 39613335 | PubTator, text mining | PubMed |
| Constitutive opening of the Kv7.2 pore activation gate causes KCNQ2-developmental encephalopathy. | Proc Natl Acad Sci U S A | 2024 | 39602259 | PubTator, text mining | PubMed |
| Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies. | Cells | 2024 | 39513870 | PubTator, text mining | PubMed |
| Therapeutic implications of etiology-specific diagnosis of early-onset developmental and epileptic encephalopathies (EO-DEEs): A nationwide Turkish cohort study. | Seizure | 2024 | 39447234 | PubTator, text mining | PubMed |
| Linking Respiratory Challenges in KCNQ2 Encephalopathy to "Phox2b" Neurons in the Retrotrapezoid Nucleus. | Epilepsy Curr | 2024 | 39309053 | PubTator, text mining | PubMed |
| Lipophilic compounds restore function to neurodevelopmental-associated KCNQ3 mutations. | Commun Biol | 2024 | 39300259 | PubTator, text mining | PubMed |
| Mid-Infrared Photons Alleviate Tinnitus by Activating the KCNQ2 Channel in the Auditory Cortex. | Research (Wash D C) | 2024 | 39296986 | PubTator, text mining | PubMed |
| Genetic Diagnosis in Neonatal Encephalopathy With Hypoxic Brain Damage Using Targeted Gene Panel Sequencing. | J Clin Neurol | 2024 | 39227335 | PubTator, text mining | PubMed |
| Involvement of HDAC2-mediated kcnq2/kcnq3 genes transcription repression activated by EREG/EGFR-ERK-Runx1 signaling in bone cancer pain. | Cell Commun Signal | 2024 | 39192337 | PubTator, text mining | PubMed |
| Donepezil as a new therapeutic potential in KCNQ2- and KCNQ3-related autism. | Front Cell Neurosci | 2024 | 39175503 | PubTator, text mining | PubMed |
| Unexpected antagonism of deoxynivalenol and enniatins in intestinal toxicity through the Ras/PI3K/AKT signaling pathway. | Toxicology | 2024 | 39153657 | PubTator, text mining | PubMed |
| Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations. | Epilepsia Open | 2024 | 39141400 | PubTator, text mining | PubMed |
| Retrospective study on neonatal seizures in a tertiary center of northern Italy after ILAE classification: Incidence, seizure type, EEG and etiology. | Epilepsy Behav | 2024 | 39094245 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3785/papers?page=8